Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Funding

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health


Xealth, the leader in enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health. Seven additional health systems ? Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care ? join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health Network, MemorialCare Innovation Fund, Providence and UPMC. This brings the company's total funding to date to $52.6 million.

Use of digital therapeutics and remote patient monitoring is accelerating as they help fill a necessary role in extending care options for patients, with a Juniper Research study predicting that the number of people using digital therapeutics and wellness apps will grow from 627 million in 2020 to more than 1.4 billion in 2025.

Available to more than 100,000 physicians, Xealth's digital health platform serves a critical role in bringing digital health into clinicians' workflow, an essential element for program success. Tightly integrated with electronic health records (EHRs), the platform supports care teams to personalize digital solution ordering with one click and helps to elevate the patient experience. Funding from this round will fuel growth of the company's team, approximately doubling its size. It will also support product innovation, including further enhancing its intelligence engine to better help health systems determine which tools are working best with which patients, further enabling the scale of Xealth's deployment across the US.

"The future of health care is using innovative technology to help people take control of their health beyond traditional care settings," said Advocate Aurora Enterprises President Scott Powder. "That's why we invested in Xealth. The company's focus on connecting a broad array of health solutions to the consumer aligns with ours, as we seek to invest in industry pioneers who are helping people live well at all stages of life."

The Xealth platform delivers centralized integration, prescribing, monitoring and governance for digital health tools from current clinician workflows, demonstrating a 50-80 percent reduction in integration and deployment costs, and substantial patient engagement with digital assets. Hospitals and providers can also leverage intelligent automation and gain insight into how each tool is performing with patients. Patients can be enrolled in beneficial programs and share information directly with care providers through the EHR.

"Digital health use is accelerating and can be a key driver of growth for hospital systems," said Mike McSherry, CEO and co-founder of Xealth. "The support from leading health systems, including Advocate Aurora, as well as The Health Management Academy, validates our approach to incorporating digital health in ways that empower both providers and patients and will elevate our growth, taking our technology vision to the next level and creating a personalized care experience that deepens the connection between patients and clinical care teams."

The Health Management Academy, which brings leading health systems and industry partners together to address the industry's biggest opportunities, helped initiate this round. Together with its members, The Academy identified Xealth as a pivotal digital health solution, creating a network effect that would benefit multiple members.

"As leading health systems pursue digital health innovation, they recognize the need to simplify the experience for physicians and streamline the process of integrating data. Xealth is a proven digital solution that addresses these challenges and enables systems to be more nimble in creating a world class digital patient experience," said Matt Gunther of The Health Management Academy.

Spun out from Providence in 2017, Xealth has backing from 14 health systems and full integrations with the largest EHR vendors. Additional investors include Cerner, LRV Health, Threshold Ventures, McKesson Ventures, Novartis, Philips, and ResMed.

About Advocate Aurora Enterprises

Advocate Aurora Enterprises (AAE) is a national leader in consumer health and wellness. It is a subsidiary of Advocate Aurora Health, one of the 12 largest not-for-profit, integrated health systems in the nation. AAE is building a portfolio of innovative consumer health and related companies that help people live well. Its three focus areas include: Aging Independently, enabling aging seniors to thrive safely and comfortably in their homes; Parenthood, supporting parents in raising healthy and happy kids with less stress and greater confidence; and Personal Performance, helping people to achieve their mind, body and nutrition goals.

About Xealth

Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients direct from the EHR workflow, send these digital health orders to the patient's email or patient portal, and then monitor activity. Xealth spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, Cerner, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network.

For more information, visit www.xealth.com or follow us on LinkedIn or Twitter.


These press releases may also interest you

at 06:05
Jumio, the leading provider of AI-powered end-to-end identity verification, eKYC and AML solutions, today announced the launch of an intuitive no-code orchestration layer for its KYX Platform that unifies an entire set of risk and fraud detection...

at 06:05
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the European Medicines Agency (EMA) has initiated a rolling review for molnupiravir, an investigational oral antiviral medicine, for the...

at 06:05
Mojenta, the first and only B2B tech marketing agency, announced today it has successfully completed 11 years in business. In that time, Mojenta has serviced nearly 300 telecom carriers, technology service distributors, managed services providers...

at 06:03
DevOps Institute (https://www.devopsinstitute.com/), a global professional association for advancing and certifying the humans of DevOps, today announced an exclusive distributor agreement and strategic partnership with Top Out Human Capital to serve...

at 06:02
Following the successful and well-received Allograft line, Neoss is excited to announce the addition of NeoGenix XPtm this autumn to our existing product portfolio. NeoGenix XPtm is a safe and clinically proven natural bone substitute, that closer...

at 06:01
ADS-TEC Energy GmbH ("ADS-TEC Energy" or "the Company"), a global leader in battery-buffered ultrafast charging technology, and Polar Structure AB ("Polar"), a platform for managing infrastructure related assets, today announced that they have...



News published on 21 september 2021 at 08:05 and distributed by: